HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,393-1,404 of 1,979
Drug study icon
CompletedNCT00322764

RG2417 for depression

Official study title

Dose-Escalating, Phase II Study to Assess the Safety and Tolerability of RG2417 in the Treatment of Bipolar I Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Stanford
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States
Sponsor
Repligen Corporation
Behavioral study icon
CompletedNCT00411463

Psychotherapy for Bipolar II Depression, Study, Phase II

Official study title

Psychotherapy for Bipolar II Depression, Pilot Study, Phase II

This study has finished and is no longer accepting participants.

In Pittsburgh
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States
Sponsor
University of Pittsburgh
Other study type icon
CompletedNCT02804867

Spot Depression Study

Official study title

A Blood Test to Identify Persons at Risk of Developing Depression or Bipolar Disorder

This study has finished and is no longer accepting participants.

In Cambridge
Depression, BipolarityObservational studyAges 18+
Countries
United Kingdom
Sponsor
University of Cambridge
Drug study icon
CompletedNCT02670551

Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in people with Bipolar I Depression

What is this study about?

Researchers compared Cariprazine and placebo to find out how the approaches affected depression symptoms in people with bipolarity type I during a depressive episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States, Bulgaria, Estonia, + 2 others
Sponsor
Forest Laboratories
Drug study icon
CompletedNCT03201757

Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831

Official study title

A Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
Schizophrenia, BipolarityMedication studyAges 16–70
Countries
United States, United Kingdom, Austria, + 9 others
Sponsor
Alkermes, Inc.
Drug study icon
CompletedNCT06993662

The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.

Official study title

The Effectiveness and Efficacy of the Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective for Patients With Mental Health Disorders

This study has finished and is no longer accepting participants.

In Athens
Personality disorders, Schizophrenia, ...Interventional studyAges 18–65
Countries
Greece
Sponsor
Rakitzi, Stavroula

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.